Skip to main content
Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
29.48
-0.61 (-2.03%)
Aug 14, 2025, 11:54 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Novel Therapeutics
1.04M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-74.11%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
1.04M
Log In
Log In
Log In
Log In
Upgrade
United States and Australia
-
Log In
Log In
Log In
Log In
Upgrade
United States and Australia Growth
-
Log In
Log In
Log In
Log In
Upgrade